Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.

Tiffin-area school children listen as Mayor Tim Kasparek speaks Sept. 16, 2025, during the groundbreaking ceremony of the ...